Business Wire

SES and Quvia to Codevelop New-Generation Multi-Orbit Solutions to Enhance Quality of Experience

24.2.2025 08:50:00 CET | Business Wire | Press Release

Share

SES is partnering with Quvia, the AI-powered quality of experience (QoE) platform formerly known as Neuron, to advance SES’s multi-orbit connectivity solutions by enhancing network orchestration capabilities. The collaboration combines SES and Quvia technologies to intelligently manage network resources and adapt dynamically to customer demand, driving enhanced QoE for SES’s mobility, enterprise and cloud customers, both companies announced today.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250223528075/en/

SES and Quvia are integrating SES’s Adaptive Resource Control (ARC) system with Quvia’s Grid and Network Capacity Controller (NCC) solutions to intelligently orchestrate SES’s multi-orbit services. NCC is the first solution to dynamically allocate satellite capacity across multiple customer endpoints. The ARC, Grid, and NCC systems will be able to communicate to analyse customer demand and respond dynamically, pushing capacity from SES’s satellite network to the edge. As a result, SES customers will get the high-quality connectivity they need, precisely when and where they need it, optimising resources, performance, and QoE.

In addition, SES is deploying Quvia’s QoE analytics solutions to measure and monitor customer QoE. Quvia’s QoE scoring system includes network, application and usage metrics, and extends across antennas, routers and third-party systems to deliver an end-to-end view of QoE from the network core to the end-user.

“Our partnership with SES marks a leap forward in multi-orbit connectivity, redefining what’s possible for global networks,” said Benny Retnamony, founder and CEO of Quvia. “By combining our expertise, we’re unlocking new levels of flexibility, reliability, and performance that directly enhance digital experiences for customers and the people who rely on their services.”

“SES is uniquely positioned as an all-orbit solutions provider. By collaborating with Quvia, SES can seamlessly deliver multi-orbit satellite connectivity services as a one-stop shop for customers, aggregating multiple links, routing traffic as needed and measuring the QoE for guaranteed levels of service. This latest partnership demonstrates our commitment to drive new opportunities that accelerate the future of connectivity and digital experiences for our customers,” said Xavier Bertrán, Chief Product & Innovation Officer of SES.

SES and Quvia at MWC25

During MWC25, SES and Quvia will demo a multi-orbit cellular backhaul solution that can provide guaranteed levels of service and QoE to enterprise customers.

Follow us on:

Twitter | Facebook | YouTube | LinkedIn | Instagram

Read our Blogs >
Visit the Media Gallery >

About SES

SES has a bold vision to deliver amazing experiences everywhere on Earth by distributing the highest quality video content and providing seamless data connectivity services around the world. As a provider of global content and connectivity solutions, SES owns and operates a geosynchronous orbit fleet and medium earth orbit (GEO-MEO) constellation of satellites, offering a combination of global coverage and high performance services. By using its intelligent, cloud-enabled network, SES delivers high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners around the world. The company is headquartered in Luxembourg and listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com

About Quvia

Quvia, formerly known as Neuron, is the first AI-powered QoE platform for ships, planes and remote sites. The platform seamlessly blends any combination of connectivity, including multiple service providers, satellite orbits and terrestrial networks, into one, vendor-neutral environment; continuously measures and analyzes real-time connectivity performance and its impact on quality of experience (QoE); and intelligently orchestrates the network to deliver the best possible QoE—even in the most remote places. Today, Quvia works with industry-leading companies in aviation, cruise, energy, shipping and more. To learn more, visit: www.quvia.ai, and follow us on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250223528075/en/

Contacts

For further information please contact:
Suzanne Ong
Communications, SES
Tel. +352 710 725 500
suzanne.ong@ses.com

Leslie Grant
VP, Marketing & Communications, Quvia
leslie@quvia.ai

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press Release

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press Release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press Release

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press Release

Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press Release

Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye